Plasma extracellular vesicle sampling from glioblastoma demonstrates a small RNA signature indicative of disease and identifies lncRNA <i>RPPH1</i> as a biomarker
The present provides preliminary data that support the continued investigation of plasma EV sRNA sampling (and particularly RPPH1) as part of a multi-pronged approach to GBM diagnosis and disease course surveillance.
Authors
- K. Attwood
- Gabriel Wajnberg (ORCID: https://orcid.org/0000-0002-4479-4063)
- Simi Chacko
- Mary MacNeil (ORCID: https://orcid.org/0000-0001-5104-6218)
- Adrienne Weeks (ORCID: https://orcid.org/0000-0001-7442-498X)
- Sidney Croul (ORCID: https://orcid.org/0000-0002-2224-5485)
- Jeremy Roy (ORCID: https://orcid.org/0000-0003-0126-1248)
- Brandon Hannay (ORCID: https://orcid.org/0000-0002-1273-332X)
- Lindsay Noiles
- Robert Cormier
- Andrea L O Hebb
- Maya Willms
- Jae Ho Han
- Matthias H Schmidt
Institutions
- Dalhousie University (CA)
- Beatrice Hunter Cancer Research Institute (CA)
- Atlantic Cancer Research Institute (CA)
Publication Details
- Journal
- Neuro-Oncology Advances
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1093/noajnl/vdaf273
- Primary Topic
- Extracellular vesicles in disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00